Patent · US Active

Bispecific anti-EGFR/anti IGF-1R antibodies

US9650442B2 · kind B2 · utility

14Cited by

0References

6Claims

0Family size

Assignee

Roche Glycart AG · CH

Inventors

Ralf Hosse · Baar, CH
Christian Klein · Iffeldorf, DE
Ekkehard Moessner · Kreuzlingen, CH
Juergen Michael Schanzer · Traunstein, DE
Cuiying Shao · Aberdeen, GB
Lei Shi · Shanghai, CN
Pablo Umana · Wollerau, CH
Peng Wang · Carlsbad, US
Katharina Wartha · Munich, DE

Key dates

Filing date	Mar 20, 2014
Grant date	May 16, 2017
Priority date	—
Expiry date	Mar 20, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/43
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to bispecific anti-EGFR/anti IGF-1R antibodies, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.